Research News

Comprehensive Study Provides Recommendations for Better Ovarian Cancer Patient Care

Key recommendations for improving care of ovarian cancer patients in the United States have been published as part of a collaborative, in-depth initiative spearheaded by the Association of Community Cancer Centers (ACCC) and involving a…

Read on

New Study Shows Surgical Removal of Fallopian Tubes Can Reduce Ovarian Cancer Risk

In promising news on the prevention front, one surgical procedure that leaves the ovaries intact may greatly reduce the risk of ovarian cancer…

Read on

The Overview: February 2022

This may be a short month, but it’s not short on all the many ways to get involved. In the meantime, we hope you feel the Valentine love from all of us at OCRA. ADVOCACY Spring Advocacy Day is right around the corner, March 7th – 8th…

Read on

New Research Shows Cervical Cells May Hold Key to Predicting Ovarian Cancer Risk

Cervical cell samples that are routinely collected as part of Pap smears may hold promise for predicting the risk of ovarian and other cancers, according to recent findings published as two separate papers in Nature — one focused on…

Read on

Study Finds Pfizer-BioNTech COVID-19 Vaccine Safe and Effective for Gynecologic Oncology Patients

A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing chemotherapy treatment around the time of their…

Read on

The Overview | January 2022

Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community…

Read on

OCRA Awards Two Ovarian Cancer Research Prizes

OCRA is pleased to announce the recipients of two research prizes, selected by members of our Scientific Advisory Committee for their notable contributions to the field of ovarian cancer research and commitment to future discoveries. Dr…

Read on

OCRA-Funded Research Points to Potential for Predicting Ovarian Cancer

New study findings not only reveal where the most common ovarian cancer subtype originates in certain patients, but also point to the future possibility of being able to predict who will get the disease…

Read on

OCRA Awards Nearly $6.5 Million in Ovarian Cancer Research Grants

More breakthroughs are on the horizon, as OCRA has awarded grants to 22 dedicated scientists at 15 prestigious medical institutions to enable future ovarian cancer discoveries…

Read on

Secondary Cytoreductive Surgery Post-Recurrence Results in Longer Overall Survival

A randomized trial recently showed that patients with an ovarian cancer recurrence who undergo cytoreductive surgery along with chemotherapy show better survival rates than those who only receive chemotherapy…

Read on

Anne van Harten, PhD | Meet a Scientist

Dr. Anne van Harten, of the Sidney Kimmel Cancer Center at Thomas Jefferson University in Philadelphia, is a 2021 recipient of OCRA’s Ann and Sol Schreiber Mentored Investigator Award…

Read on

OCRA-Funded Research Reveals How Distinct Mutational Processes May Affect HGSOC Tumor Growth

OCRA grantees Ignacio Vázquez-García, PhD and Sohrab Shah, PhD, of Memorial Sloan Kettering Cancer Center, along with colleagues, have found that distinct mutational processes determine the different mechanisms by which certain…

Read on